ESR1 and breast cancer: Few studies (Gupta et al. 2017; Peterson et al. 2011) yielded good correlation of 18F-FES and ER-expression in breast cancer, with higher 18F-FES uptake in higher ER-expressing tumor cells, resulting in an increased detection rate.